Abstract:Background: Classical galactosemia (CG), an inborn error of galactose metabolism, results in long-term complications including cognitive impairment and movement disorders, despite early diagnosis and dietary treatment. Two decades ago, lower motor-, cognitive- and social health related quality of life (HRQoL) was demonstrated in pediatric and adult patients. Since then, the diet has been relaxed, newborn screening was implemented and new international guidelines resulted in major changes in follow-up. The aim of this study was to assess HRQoL of CG by means of online self- and/or proxy-HRQoL-questionnaires focusing on the main areas of concern of CG (i.e. anxiety, depression, cognition, fatigue, social- and upper extremity function) within the patient-reported outcomes measurement information system (PROMIS®) and generic HRQoL-questionnaires (TAPQOL, TACQOL, TAAQOL). Results: Data of 61 Dutch patients (aged 1-52 years) were collected and compared to available Dutch or US reference populations. On the PROMIS-questionnaires, children reported more fatigue (P = 0.044), lower function in upper extremities (P = 0.021), more cognitive difficulties (P = 0.055, d = 0.56) and higher anxiety (P = 0.063, d = 0.52) than reference children although the latter findings remained non-significant. Parents of CG patients reported lower quality of peer relationships of their children (P < 0.001). Both children and parents reported lower cognitive functioning (P = 0.005, P = 0.010) on the TACQOL. Adults reported on PROMIS domains lower cognitive functioning (P = 0.030), higher anxiety (P = 0.004) and more fatigue (P = 0.026). Cognitive difficulties were reported on the TAAQOL by adults (P < 0.001), as well as physical-, sleeping and social difficulties. Conclusions: CG remains to impact the HRQoL of pediatric and adult patients negatively on several domains including cognition, anxiety, motor function and fatigue. A lower social health was mainly reported by parents, and not by patients themselves. The Covid-19 pandemic might have amplified the results on anxiety although higher levels of anxiety fit pre-pandemic findings. The reported fatigue is a new finding in CG. Because the effect of lockdown fatigue could not be eliminated and fatigue is a frequent finding in patients with chronic disorders, future studies are warranted. Clinicians and researchers should be attentive to both pediatric and adult patients, and the age-dependent difficulties they might encounter.

Natural history of three late-diagnosed classic Galactosemia patients

Literature review on congenital glucose-galactose malabsorption from 2001 to 2019

The natural history of classic galactosemia: lessons from the GalNet registry

Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency

Health and well-being of maturing adults with classic galactosemia

Brain function in classic galactosemia, a galactosemia network (GalNet) members review

The Adult Galactosemic Phenotype.

Classic Galactosemia: Study on the Late Prenatal Development of GALT Specific Activity in a Sheep Model

A case report of classic galactosemia with a GALT gene variant and a literature review

Social cognition, emotion-regulation and social competence in classical galactosemia patients without intellectual disability

N- and O-linked Glycosylation of Total Plasma Glycoproteins in Galactosemia.

International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up

Importance of genetic sequencing studies in managing chronic neonatal diarrhea: a case report of a novel variant in the glucose–galactose transporter SLC5A1

The challenges of classical galactosemia: HRQoL in pediatric and adult patients

Diagnosis of Inherited Disorders of Galactose Metabolism

A galactose‐1‐phosphate uridylyltransferase‐null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue‐specific and longitudinal differences in galactose metabolism

Determination of the lactose and galactose content of common foods: Relevance to galactosemia

Social cognition, psychosocial development and well-being in galactosemia

The natural history of Gaucher disease type 1 in 31 patients over a median of 15 years: a retrospective study

Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG

Long-term outcomes in ALG13-Congenital Disorder of Glycosylation